整合放射敏感性指数与放射抵抗相关指数改善前列腺癌预后预测
本研究基于基因表达综合数据库和癌症基因组图谱的前列腺癌转录组数据,验证31基因特征、放射敏感性指数和放射抵抗相关基因指数的预测潜力,并通过Cox分析和LASSO回归构建4种前列腺癌相关放射敏感性预测指数。其中14Genes模型预测性能和区分能力最佳,基于此建立的列线图在前列腺癌患者复发预测中表现优异;接受放疗的患者可用20Genes和RRRI模型预测无复发生存,20Genes更具放疗特异性但需进一步外部验证。
要点
- 14Genes模型在癌症基因组图谱和GSE队列中ROC曲线下面积和决策树变量重要性最高。
- 基于14Genes等建立的放射敏感性相关列线图在前列腺癌复发预测中表现优异。
- 接受放疗的前列腺癌患者可用20Genes和RRRI模型预测无复发生存。
核心结论
- 本研究成功建立了放射敏感性相关列线图,在前列腺癌患者复发预测中表现优异。
- 接受放疗的患者可用20Genes和RRRI模型预测无复发生存,20Genes更具放疗特异性但需进一步外部验证。
研究设计与样本
- 从前列腺癌转录组数据中验证31基因特征、放射敏感性指数和放射抵抗相关基因指数的预测潜力。
- 通过Cox分析和LASSO回归分析4种基于31-GS、RSI和RRRI的前列腺癌相关放射敏感性预测指数。
- 使用时间依赖ROC曲线、决策曲线分析、综合判别改善指数、净重分类改善指数和决策树模型比较4种基因特征的放射敏感性预测能力。
- 通过加权基因共表达网络分析和基因功能富集分析识别关键模块及相关功能。
- 建立列线图以提高复发预测能力。
主要发现
- 验证并比较了2种已发表预测指数的预测潜力。
- 基于31-GS、RSI和RRRI分析了4种前列腺癌相关放射敏感性预测指数:14Genes、RSI、RRRI和20Genes。
- 14Genes表现出最有希望的预测性能和区分能力。
- 14Genes模型定义的关键模块中的基因显著富集于放疗相关细胞死亡通路。
- 14Genes在癌症基因组图谱和基因表达综合数据库系列(GSE)队列中的ROC曲线下面积和决策树变量重要性最高。
关键数值与推荐
- 14Genes模型在癌症基因组图谱和GSE队列中ROC曲线下面积和决策树变量重要性最高。
- 接受放疗的患者可用20Genes和RRRI模型预测无复发生存。
- 20Genes更具放疗特异性但需进一步外部验证。
临床怎么用
- 基于14Genes等建立的放射敏感性相关列线图可用于预测前列腺癌患者复发。
- 接受放疗的前列腺癌患者可使用20Genes和RRRI模型预测无复发生存。
- 20Genes模型更具放疗特异性,但需进一步外部验证。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to establish a nomogram combining 31-gene signature (31-GS), radiosensitivity index (RSI), and radiation-resistance-related gene index (RRRI) to predict recurrence in prostate cancer (PCa) patients. METHODS AND MATERIALS: Transcriptome data of PCa were obtained from gene expression omnibus and the cancer genome atlas to validate the predictive potential of 3 sets of published biomarkers, namely, 31-GS, RSI, and RRRI. To adjust these markers for the characteristics of PCa, we analyzed 4 PCa-associated radiosensitivity predictive indices based on 31-GS, RSI, and RRRI by the Cox analysis and least absolute shrinkage and selection operator regression analysis. Time-dependent receiver operating characteristic curves, decision curve analyses, integrated discrimination improvement, net reclassification improvement and decision tree model construction were used to compare the radiosensitivity predictive ability of these 4 gene signatures. Key modules and associated functions were identified through a weighted gene co-expression network analysis and gene function enrichment analysis. A nomogram was built to improve the recurrence-prediction capability. RESULTS: We validated and compared the predictive potential of 2 published predictive indices. Based on the 31-GS, RSI, and RRRI, we analyzed 4 PCa-associated radiosensitivity predictive indices: 14Genes, RSI, RRRI, and 20Genes. Among them, 14Genes showed the most promising predictive performance and discriminative capacity. Genes in the key module defined by the 14Genes model were significantly enriched in radiation therapy-related cell death pathways. The area under receiver operating characteristic curve and decision tree variable importance for 14Genes was the highest in the cancer genome atlas and Gene Expression Omnibus Series (GSE) cohorts. CONCLUSIONS: This study successfully established a radiosensitivity-related nomogram, which had excellent performance in predicting recurrence in patients with PCa. For patients who received radiation therapy, the 20Genes and RRRI models can be used to predict recurrence-free survival, whereas 20Genes is more radiation therapy-specific but needs further external validation.
引用
- Wu QQ, Yin ZS, Zhang Y, et al. Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction. Adv Radiat Oncol. 2025. PMID: 40034476. doi:10.1016/j.adro.2025.101713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。